ERNA · Ernexa Therapeutics Inc. · Executive Compensation
$2.24
+0.26 (+13.13%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of June 30, 2026, the Company had approximately $5.0 million in cash, which is less than that needed to effect its current operating plan and forecasted cash requirements for the next twelve months. However, management expects that its ability to access capital under its ATM will cover shortfalls in its cash resources over the next twelve months from the issuance date of these financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$3.66M
Shares
1.63M
Volume · Oct 20
47.96K
Avg daily vol (3M)
56.94K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Allen Wolff | Former Chief Executive Officer | $594,040 |
| Sandra Gurrola | Vice President of Finance | $374,246 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Allen Wolff | Former Chief Executive Officer | $302,200 |
| Sandra Gurrola | Vice President of Finance | $205,396 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert J. Spiegel, M.D. | member of the Board | Appointed | 2026-09-16 |
| Sandra Gurrola | Senior Vice President of Finance | Resigned | 2026-06-26 |
| Dr. Elena Ratner | Board | Appointed | 2025-01-10 |
| Dorothy Clarke | Board of Directors | Resigned | 2025-01-10 |
| Peter Cicala | member of the Board | Appointed | 2024-02-16 |
| Sanjeev Luther | member of the Company's Board of Directors | Appointed | 2023-12-20 |
| James Bristol | chairman of the Board | Appointed | 2023-12-20 |
| Sanjeev Luther | President and Chief Executive Officer (and principal executive officer) | Appointed | 2023-12-20 |
| Dr. Matthew Angel | President and Chief Executive Officer | Resigned | 2023-12-20 |
| Dr. James Bristol | director | Appointed | 2023-11-01 |
| Gregory Fiore | board of directors | Resigned | 2023-10-05 |
| Dorothy J. Clarke | director | Appointed | 2023-08-31 |
| Dr. Matthew Angel | President and Chief Executive Officer (principal executive officer) | Appointed | 2023-08-10 |
| Richard W. Wagner | Board | Resigned | 2023-08-10 |
| Brant C. Binder | Board | Resigned | 2023-08-10 |
| Dr. Matthew Angel | Board | Resigned | 2023-08-10 |
| Dr. Matthew Angel | President and Chief Executive Officer | Resigned | 2023-08-10 |
| Richard W. Wagner | director | Appointed | 2023-07-11 |
| Brant C. Binder | director | Appointed | 2023-07-11 |
| Charles Cherington | the Board | Resigned | 2023-07-11 |
| Nicholas Singer | the Board | Resigned | 2023-07-11 |
| Andrew Jackson | Chief Financial Officer (principal financial officer) | Resigned | 2023-05-05 |
| Sandra Gurrola | principal financial officer | Appointed | 2023-05-05 |
| Dr. Roger Sidhu | Chief Medical Officer | Resigned | 2023-01-26 |
| Dr. Matthew Angel | President and Chief Executive Officer | Appointed | 2023-01-04 |
Leadership
- Dr. Matthew Angel CEO
- Matt Angel, Ph.D. CEO
- Sanjeev Luther CEO, Board Member
- Allen Wolff Chairman, Board Member
- James Bristol Chairman
- Luba Greenwood Chairman, Board Member
- Sandra Gurrola CFO
- Dorothy Clarke General Counsel
- Brant C. Binder Board Member
- Dennis H. Langer Board Member
- Dorothy J. Clarke Board Member
- Dr. Elena Ratner Board Member
- Dr. James Bristol Board Member
- Elena Ratner Board Member
- Erich Mohr Board Member
- Erin S. Enright Board Member
- George P. Denny III Board Member
- Heather B. Redman Board Member
- Howard J. Federoff Board Member
- Peter Cicala Board Member
- Richard W. Wagner Board Member
- Robert J. Spiegel, M.D. Board Member
- William Wexler Board Member
- Yiannis Monovoukas Board Member